Stearoyl-CoA desaturase-1 and adaptive stress signaling

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1861, Issue 11, 2016, Pages 1719-1726

  Koeberle, Andreas ^a   Löser, Konstantin ^a   Thürmer, Maria ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Endoplasmic reticulum; Lipidomics; Lipotoxicity; Monounsaturated fatty acid; Stearoyl CoA desaturase; Stress adaption

Indexed keywords

ACYL COENZYME A DESATURASE 1; INSULIN; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; ACYL COENZYME A DESATURASE;

AUTOPHAGY; CELL SIGNALING ASSAY; CELL SURVIVAL; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME STRUCTURE; HOMEOSTASIS; HUMAN; METABOLISM; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; UNFOLDED PROTEIN RESPONSE; ANIMAL; BIOCATALYSIS; BIOLOGICAL MODEL; CHEMISTRY; PHYSIOLOGICAL STRESS;

ANIMALS; BIOCATALYSIS; CELL SURVIVAL; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; STEAROYL-COA DESATURASE; STRESS, PHYSIOLOGICAL;

EID: 84983364801     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2016.08.009     Document Type: Review

References (116)

1. [1] Galluzzi, L., Bravo-San Pedro, J.M., Kepp, O., Kroemer, G., Regulated cell death and adaptive stress responses. Cell. Mol. Life Sci. 73 (2016), 2405–2410.
2. [2] Wetzker, R., Rubio, I., Hormetic signaling patterns. Dose-Response 10 (2012), 83–90.
3. [3] Hodson, L., Fielding, B.A., Stearoyl-CoA desaturase: rogue or innocent bystander?. Prog. Lipid Res. 52 (2013), 15–42.
4. [4] Liu, X., Strable, M.S., Ntambi, J.M., Stearoyl CoA desaturase 1: role in cellular inflammation and stress. Adv. Nutr. 2 (2011), 15–22.
5. [5] Igal, R.A., Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 31 (2010), 1509–1515.
6. [6] Dobrzyn, P., Bednarski, T., Dobrzyn, A., Metabolic reprogramming of the heart through stearoyl-CoA desaturase. Prog. Lipid Res. 57 (2015), 1–12.
7. [7] Sampath, H., Ntambi, J.M., Role of stearoyl-CoA desaturase-1 in skin integrity and whole body energy balance. J. Biol. Chem. 289 (2014), 2482–2488.
8. [8] Sampath, H., Ntambi, J.M., The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation. Ann. N. Y. Acad. Sci. 1243 (2011), 47–53.
9. [9] Stamatikos, A.D., Paton, C.M., Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism. Am. J. Phys. 305 (2013), E767–E775.
10. [10] Zhang, Z., Dales, N.A., Winther, M.D., Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease. J. Med. Chem. 57 (2014), 5039–5056.
11. [11] Uto, Y., Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors. Chem. Phys. Lipids 197 (2016), 3–12.
12. [12] Enoch, H.G., Catala, A., Strittmatter, P., et al. J. Biol. Chem. 251 (1976), 5095–5103.
13. [13] Hermansson, M., Hokynar, K., Somerharju, P., Mechanisms of glycerophospholipid homeostasis in mammalian cells. Prog. Lipid Res. 50 (2011), 240–257.
14. [14] Hishikawa, D., Hashidate, T., Shimizu, T., Shindou, H., Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells. J. Lipid Res. 55 (2014), 799–807.
15. [15] Mihara, K., Structure and regulation of rat liver microsomal stearoyl-CoA desaturase gene. J. Biochem. 108 (1990), 1022–1029.
16. [16] Ntambi, J.M., Buhrow, S.A., Kaestner, K.H., Christy, R.J., Sibley, E., Kelly, T.J. Jr., Lane, M.D., Differentiation-induced gene expression in 3T3-L1 preadipocytes. Characterization of a differentially expressed gene encoding stearoyl-CoA desaturase. J. Biol. Chem. 263 (1988), 17291–17300.
17. [17] Zheng, Y., Eilertsen, K.J., Ge, L., Zhang, L., Sundberg, J.P., Prouty, S.M., Stenn, K.S., Parimoo, S., Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat. Genet. 23 (1999), 268–270.
18. [18] Ariyama, H., Kono, N., Matsuda, S., Inoue, T., Arai, H., Decrease in membrane phospholipid unsaturation induces unfolded protein response. J. Biol. Chem. 285 (2010), 22027–22035.
19. [19] Dobrzyn, A., Dobrzyn, P., Miyazaki, M., Sampath, H., Chu, K., Ntambi, J.M., Stearoyl-CoA desaturase 1 deficiency increases CTP:choline cytidylyltransferase translocation into the membrane and enhances phosphatidylcholine synthesis in liver. J. Biol. Chem. 280 (2005), 23356–23362.
20. [20] Miyazaki, M., Kim, Y.C., Gray-Keller, M.P., Attie, A.D., Ntambi, J.M., The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J. Biol. Chem. 275 (2000), 30132–30138.
21. [21] Koeberle, A., Pergola, C., Shindou, H., Koeberle, S.C., Shimizu, T., Laufer, S.A., Werz, O., Role of p38 mitogen-activated protein kinase in linking stearoyl-CoA desaturase-1 activity with endoplasmic reticulum homeostasis. FASEB J. 29 (2015), 2439–2449.
22. [22] Mauvoisin, D., Mounier, C., Hormonal and nutritional regulation of SCD1 gene expression. Biochimie 93 (2011), 78–86.
23. [23] Miyazaki, M., Man, W.C., Ntambi, J.M., Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. J. Nutr. 131 (2001), 2260–2268.
24. [24] Ntambi, J.M., Miyazaki, M., Stoehr, J.P., Lan, H., Kendziorski, C.M., Yandell, B.S., Song, Y., Cohen, P., Friedman, J.M., Attie, A.D., Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 11482–11486.
25. [25] Ntambi, J.M., Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid Res. 40 (1999), 1549–1558.
26. [26] Gautron, L., Elmquist, J.K., Sixteen years and counting: an update on leptin in energy balance. J. Clin. Invest. 121 (2011), 2087–2093.
27. [27] Turyn, J., Stojek, M., Swierczynski, J., Up-regulation of stearoyl-CoA desaturase 1 and elongase 6 genes expression in rat lipogenic tissues by chronic food restriction and chronic food restriction/refeeding. Mol. Cell. Biochem. 345 (2010), 181–188.
28. [28] Lee, K.N., Pariza, M.W., Ntambi, J.M., Differential expression of hepatic stearoyl-CoA desaturase gene 1 in male and female mice. Biochim. Biophys. Acta 1304 (1996), 85–88.
29. [29] Zhang, X., Liu, J., Su, W., Wu, J., Wang, C., Kong, X., Gustafsson, J.A., Ding, J., Ma, X., Guan, Y., Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRalpha-SREBP1c-dependent mechanism. J Diabetes 6 (2014), 212–220.
30. [30] Antony, N., Weir, J.R., McDougall, A.R., Mantamadiotis, T., Meikle, P.J., Cole, T.J., Bird, A.D., cAMP response element binding protein1 is essential for activation of steroyl co-enzyme a desaturase 1 (Scd1) in mouse lung type II epithelial cells. PLoS One, 8, 2013, e59763.
31. [31] Mziaut, H., Korza, G., Ozols, J., The N terminus of microsomal delta 9 stearoyl-CoA desaturase contains the sequence determinant for its rapid degradation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 8883–8888.
32. [32] Kato, H., Sakaki, K., Mihara, K., Ubiquitin-proteasome-dependent degradation of mammalian ER stearoyl-CoA desaturase. J. Cell Sci. 119 (2006), 2342–2353.
33. [33] Heinemann, F.S., Ozols, J., Degradation of stearoyl-coenzyme A desaturase: endoproteolytic cleavage by an integral membrane protease. Mol. Biol. Cell 9 (1998), 3445–3453.
34. [34] Schwenk, R.W., Jonas, W., Ernst, S.B., Kammel, A., Jahnert, M., Schurmann, A., Diet-dependent alterations of hepatic Scd1 expression are accompanied by differences in promoter methylation. Horm. Metab. Res. 45 (2013), 786–794.
35. [35] Martin-Nunez, G.M., Cabrera-Mulero, R., Rubio-Martin, E., Rojo-Martinez, G., Olveira, G., Valdes, S., Soriguer, F., Castano, L., Morcillo, S., Methylation levels of the SCD1 gene promoter and LINE-1 repeat region are associated with weight change: an intervention study. Mol. Nutr. Food Res. 58 (2014), 1528–1536.
36. [36] Lee, S.H., Dobrzyn, A., Dobrzyn, P., Rahman, S.M., Miyazaki, M., Ntambi, J.M., Lack of stearoyl-CoA desaturase 1 upregulates basal thermogenesis but causes hypothermia in a cold environment. J. Lipid Res. 45 (2004), 1674–1682.
37. [37] Sampath, H., Flowers, M.T., Liu, X., Paton, C.M., Sullivan, R., Chu, K., Zhao, M., Ntambi, J.M., Skin-specific deletion of stearoyl-CoA desaturase-1 alters skin lipid composition and protects mice from high fat diet-induced obesity. J. Biol. Chem. 284 (2009), 19961–19973.
38. [38] Gutierrez-Juarez, R., Pocai, A., Mulas, C., Ono, H., Bhanot, S., Monia, B.P., Rossetti, L., Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J. Clin. Invest. 116 (2006), 1686–1695.
39. [39] Narce, M., Bellenger, J., Rialland, M., Bellenger, S., Recent advances on stearoyl-Coa desaturase regulation in fatty liver diseases. Curr. Drug Metab. 13 (2012), 1454–1463.
40. [40] Roongta, U.V., Pabalan, J.G., Wang, X., Ryseck, R.P., Fargnoli, J., Henley, B.J., Yang, W.P., Zhu, J., Madireddi, M.T., Lawrence, R.M., Wong, T.W., Rupnow, B.A., Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol. Cancer Res. 9 (2011), 1551–1561.
41. [41] Mason, P., Liang, B., Li, L., Fremgen, T., Murphy, E., Quinn, A., Madden, S.L., Biemann, H.P., Wang, B., Cohen, A., Komarnitsky, S., Jancsics, K., Hirth, B., Cooper, C.G., Lee, E., Wilson, S., Krumbholz, R., Schmid, S., Xiang, Y., Booker, M., Lillie, J., Carter, K., SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS One, 7, 2012, e33823.
42. [42] Chen, L., Ren, J., Yang, L., Li, Y., Fu, J., Li, Y., Tian, Y., Qiu, F., Liu, Z., Qiu, Y., Stearoyl-CoA desaturase-1 mediated cell apoptosis in colorectal cancer by promoting ceramide synthesis. Sci. Rep., 6, 2016, 19665.
43. [43] Fritz, V., Benfodda, Z., Rodier, G., Henriquet, C., Iborra, F., Avances, C., Allory, Y., de la Taille, A., Culine, S., Blancou, H., Cristol, J.P., Michel, F., Sardet, C., Fajas, L., Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol. Cancer Ther. 9 (2010), 1740–1754.
44. [44] Du, X., Wang, Q.R., Chan, E., Merchant, M., Liu, J., French, D., Ashkenazi, A., Qing, J., FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth. Cancer Res. 72 (2012), 5843–5855.
45. [45] Scaglia, N., Igal, R.A., Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. Int. J. Oncol. 33 (2008), 839–850.
46. [46] Theodoropoulos, P.C., Gonzales, S.S., Winterton, S.E., Rodriguez-Navas, C., McKnight, J.S., Morlock, L.K., Hanson, J.M., Cross, B., Owen, A.E., Duan, Y., Moreno, J.R., Lemoff, A., Mirzaei, H., Posner, B.A., Williams, N.S., Ready, J.M., Nijhawan, D., Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase. Nat. Chem. Biol. 12 (2016), 218–225.
47. [47] Pharma, X., XEN801 for the treatment of acne. http://www.xenon-pharma.com/product-candidates/dermatologic/, 2015.
48. [48] Wang, H., Klein, M.G., Zou, H., Lane, W., Snell, G., Levin, I., Li, K., Sang, B.C., Crystal structure of human stearoyl-coenzyme A desaturase in complex with substrate. Nat. Struct. Mol. Biol. 22 (2015), 581–585.
49. [49] Bai, Y., McCoy, J.G., Levin, E.J., Sobrado, P., Rajashankar, K.R., Fox, B.G., Zhou, M., X-ray structure of a mammalian stearoyl-CoA desaturase. Nature 524 (2015), 252–256.
50. [50] Flowers, M.T., Keller, M.P., Choi, Y., Lan, H., Kendziorski, C., Ntambi, J.M., Attie, A.D., Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet. Physiol. Genomics 33 (2008), 361–372.
51. [51] Clamp, A.G., Ladha, S., Clark, D.C., Grimble, R.F., Lund, E.K., The influence of dietary lipids on the composition and membrane fluidity of rat hepatocyte plasma membrane. Lipids 32 (1997), 179–184.
52. [52] Rintoul, D.A., Sklar, L.A., Simoni, R.D., Membrane lipid modification of chinese hamster ovary cells. Thermal properties of membrane phospholipids. J. Biol. Chem. 253 (1978), 7447–7452.
53. [53] Braig, S., Schmidt, S., Stoiber, K., Händel, C., Möhn, T., Werz, O., Müller, R., Zahler, S., Koeberle, A., Käs, J.A., Vollmar, A.M., Pharmacological targeting of membrane rigidity: implications on cancer cell migration and invasion. New J. Phys., 17, 2015, 083007.
54. [54] Lyn, R.K., Singaravelu, R., Kargman, S., O'Hara, S., Chan, H., Oballa, R., Huang, Z., Jones, D.M., Ridsdale, A., Russell, R.S., Partridge, A.W., Pezacki, J.P., Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes. Sci. Rep., 4, 2014, 4549.
55. [55] Tan, S.H., Shui, G., Zhou, J., Shi, Y., Huang, J., Xia, D., Wenk, M.R., Shen, H.M., Critical role of SCD1 in autophagy regulation via lipogenesis and lipid rafts-coupled AKT-FOXO1 signaling pathway. Autophagy 10 (2014), 226–242.
56. [56] Vinknes, K.J., Elshorbagy, A.K., Drevon, C.A., Nurk, E., Tell, G.S., Nygard, O., Vollset, S.E., Refsum, H., Associations between plasma polyunsaturated fatty acids, plasma stearoyl-CoA desaturase indices and body fat. Obesity (Silver Spring) 21 (2013), E512–E519.
57. [57] Ralston, J.C., Mutch, D.M., SCD1 inhibition during 3T3-L1 adipocyte differentiation remodels triacylglycerol, diacylglycerol and phospholipid fatty acid composition. Prostaglandins Leukot. Essent. Fatty Acids 98 (2015), 29–37.
58. [58] Shimizu, T., Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 49 (2009), 123–150.
59. [59] Koeberle, A., Shindou, H., Koeberle, S.C., Laufer, S.A., Shimizu, T., Werz, O., Arachidonoyl-phosphatidylcholine oscillates during the cell cycle and counteracts proliferation by suppressing Akt membrane binding. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 2546–2551.
60. [60] Koeberle, A., Shindou, H., Harayama, T., Shimizu, T., Palmitoleate is a mitogen, formed upon stimulation with growth factors, and converted to palmitoleoyl-phosphatidylinositol. J. Biol. Chem. 287 (2012), 27244–27254.
61. [61] Dobrzyn, P., Jazurek, M., Dobrzyn, A., Stearoyl-CoA desaturase and insulin signaling—what is the molecular switch?. Biochim. Biophys. Acta 1797 (2010), 1189–1194.
62. [62] Bedinger, D.H., Adams, S.H., Metabolic, anabolic, and mitogenic insulin responses: a tissue-specific perspective for insulin receptor activators. Mol. Cell. Endocrinol. 415 (2015), 143–156.
63. [63] Hers, I., Vincent, E.E., Tavare, J.M., Akt signalling in health and disease. Cell. Signal. 23 (2011), 1515–1527.
64. [64] Rahman, S.M., Dobrzyn, A., Dobrzyn, P., Lee, S.H., Miyazaki, M., Ntambi, J.M., Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 11110–11115.
65. [65] McGarry, J.D., Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002), 7–18.
66. [66] Calvisi, D.F., Wang, C., Ho, C., Ladu, S., Lee, S.A., Mattu, S., Destefanis, G., Delogu, S., Zimmermann, A., Ericsson, J., Brozzetti, S., Staniscia, T., Chen, X., Dombrowski, F., Evert, M., Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140 (2011), 1071–1083.
67. [67] Hardie, D.G., Molecular pathways: is AMPK a friend or a foe in cancer?. Clin. Cancer Res. 21 (2015), 3836–3840.
68. [68] Ruderman, N.B., Carling, D., Prentki, M., Cacicedo, J.M., AMPK, insulin resistance, and the metabolic syndrome. J. Clin. Invest. 123 (2013), 2764–2772.
69. [69] Dobrzyn, P., Dobrzyn, A., Miyazaki, M., Cohen, P., Asilmaz, E., Hardie, D.G., Friedman, J.M., Ntambi, J.M., Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 6409–6414.
70. [70] Dobrzyn, A., Dobrzyn, P., Lee, S.H., Miyazaki, M., Cohen, P., Asilmaz, E., Hardie, D.G., Friedman, J.M., Ntambi, J.M., Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 288 (2005), E599–E607.
71. [71] Miyazaki, M., Dobrzyn, A., Man, W.C., Chu, K., Sampath, H., Kim, H.J., Ntambi, J.M., Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J. Biol. Chem. 279 (2004), 25164–25171.
72. [72] Hetz, C., Chevet, E., Oakes, S.A., Proteostasis control by the unfolded protein response. Nat. Cell Biol. 17 (2015), 829–838.
73. [73] Thorn, K., Hovsepyan, M., Bergsten, P., Reduced levels of SCD1 accentuate palmitate-induced stress in insulin-producing beta-cells. Lipids Health Dis., 9, 2010, 108.
74. [74] Ikeda, J., Ichiki, T., Takahara, Y., Kojima, H., Sankoda, C., Kitamoto, S., Tokunou, T., Sunagawa, K., PPARgamma agonists attenuate palmitate-induced ER stress through up-regulation of SCD-1 in macrophages. PLoS One, 10, 2015, e0128546.
75. [75] Flowers, J.B., Rabaglia, M.E., Schueler, K.L., Flowers, M.T., Lan, H., Keller, M.P., Ntambi, J.M., Attie, A.D., Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice. Diabetes 56 (2007), 1228–1239.
76. [76] Scaglia, N., Tyekucheva, S., Zadra, G., Photopoulos, C., Loda, M., De novo fatty acid synthesis at the mitotic exit is required to complete cellular division. Cell Cycle 13 (2014), 859–868.
77. [77] Qin, X., Tian, J., Zhang, P., Fan, Y., Chen, L., Guan, Y., Fu, Y., Zhu, Y., Chien, S., Wang, N., Laminar shear stress up-regulates the expression of stearoyl-CoA desaturase-1 in vascular endothelial cells. Cardiovasc. Res. 74 (2007), 506–514.
78. [78] Ralston, J.C., Metherel, A.H., Stark, K.D., Mutch, D.M., SCD1 mediates the influence of exogenous saturated and monounsaturated fatty acids in adipocytes: effects on cellular stress, inflammatory markers and fatty acid elongation. J. Nutr. Biochem. 27 (2016), 241–248.
79. [79] Peter, A., Weigert, C., Staiger, H., Machicao, F., Schick, F., Machann, J., Stefan, N., Thamer, C., Haring, H.U., Schleicher, E., Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 58 (2009), 1757–1765.
80. [80] Busch, A.K., Gurisik, E., Cordery, D.V., Sudlow, M., Denyer, G.S., Laybutt, D.R., Hughes, W.E., Biden, T.J., Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic beta-cells from lipoapoptosis. Diabetes 54 (2005), 2917–2924.
81. [81] Peter, A., Weigert, C., Staiger, H., Rittig, K., Cegan, A., Lutz, P., Machicao, F., Haring, H.U., Schleicher, E., Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity. Am. J. Physiol. Endocrinol. Metab. 295 (2008), E339–E349.
82. [82] Jiang, X., Overholtzer, M., Thompson, C.B., Autophagy in cellular metabolism and cancer. J. Clin. Invest. 125 (2015), 47–54.
83. [83] Rashid, H.O., Yadav, R.K., Kim, H.R., Chae, H.J., ER stress: autophagy induction, inhibition and selection. Autophagy 11 (2015), 1956–1977.
84. [84] Hamasaki, M., Furuta, N., Matsuda, A., Nezu, A., Yamamoto, A., Fujita, N., Oomori, H., Noda, T., Haraguchi, T., Hiraoka, Y., Amano, A., Yoshimori, T., Autophagosomes form at ER-mitochondria contact sites. Nature 495 (2013), 389–393.
85. [85] Reunanen, H., Punnonen, E.L., Hirsimaki, P., Studies on vinblastine-induced autophagocytosis in mouse liver. V. A cytochemical study on the origin of membranes. Histochemistry 83 (1985), 513–517.
86. [86] Huang, G.M., Jiang, Q.H., Cai, C., Qu, M., Shen, W., SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway. Cancer Lett. 358 (2015), 180–190.
87. [87] Ogasawara, Y., Itakura, E., Kono, N., Mizushima, N., Arai, H., Nara, A., Mizukami, T., Yamamoto, A., Stearoyl-CoA desaturase 1 activity is required for autophagosome formation. J. Biol. Chem. 289 (2014), 23938–23950.
88. [88] Janikiewicz, J., Hanzelka, K., Dziewulska, A., Kozinski, K., Dobrzyn, P., Bernas, T., Dobrzyn, A., Inhibition of SCD1 impairs palmitate-derived autophagy at the step of autophagosome-lysosome fusion in pancreatic beta-cells. J. Lipid Res. 56 (2015), 1901–1911.
89. [89] Wagner, E.F., Nebreda, A.R., Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9 (2009), 537–549.
90. [90] Kim, I., Xu, W., Reed, J.C., Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7 (2008), 1013–1030.
91. [91] Ranganathan, A.C., Zhang, L., Adam, A.P., Aguirre-Ghiso, J.A., Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res. 66 (2006), 1702–1711.
92. [92] Wang, X.Z., Ron, D., Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science 272 (1996), 1347–1349.
93. [93] Mauvoisin, D., Charfi, C., Lounis, A.M., Rassart, E., Mounier, C., Decreasing stearoyl-CoA desaturase-1 expression inhibits beta-catenin signaling in breast cancer cells. Cancer Sci. 104 (2013), 36–42.
94. [94] Rios-Esteves, J., Resh, M.D., Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins. Cell Rep. 4 (2013), 1072–1081.
95. [95] Nile, A.H., Hannoush, R.N., Fatty acylation of Wnt proteins. Nat. Chem. Biol. 12 (2016), 60–69.
96. [96] Takada, R., Satomi, Y., Kurata, T., Ueno, N., Norioka, S., Kondoh, H., Takao, T., Takada, S., Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev. Cell 11 (2006), 791–801.
97. [97] Janda, C.Y., Waghray, D., Levin, A.M., Thomas, C., Garcia, K.C., Structural basis of Wnt recognition by Frizzled. Science 337 (2012), 59–64.
98. [98] Liu, J., Cinar, R., Xiong, K., Godlewski, G., Jourdan, T., Lin, Y., Ntambi, J.M., Kunos, G., Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 18832–18837.
99. [99] Brown, W.H., Gillum, M.P., Lee, H.Y., Camporez, J.P., Zhang, X.M., Jeong, J.K., Alves, T.C., Erion, D.M., Guigni, B.A., Kahn, M., Samuel, V.T., Cravatt, B.F., Diano, S., Shulman, G.I., Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 14966–14971.
100. [100] Hara, T., Kashihara, D., Ichimura, A., Kimura, I., Tsujimoto, G., Hirasawa, A., Role of free fatty acid receptors in the regulation of energy metabolism. Biochim. Biophys. Acta 1841 (2014), 1292–1300.
101. [101] Semple, R.K., Chatterjee, V.K., O'Rahilly, S., PPAR gamma and human metabolic disease. J. Clin. Invest. 116 (2006), 581–589.
102. [102] Dopico, A.M., Bukiya, A.N., Lipid regulation of BK channel function. Front. Physiol., 5, 2014, 312.
103. [103] Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., Flier, J.S., TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116 (2006), 3015–3025.
104. [104] Holzer, R.G., Park, E.J., Li, N., Tran, H., Chen, M., Choi, C., Solinas, G., Karin, M., Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 147 (2011), 173–184.
105. [105] Volmer, R., van der Ploeg, K., Ron, D., Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 4628–4633.
106. [106] Koeberle, A., Werz, O., Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders. Biochem. Pharmacol. 98 (2015), 1–15.
107. [107] Allred, J.B., Reilly, K.E., Short-term regulation of acetyl CoA carboxylase in tissues of higher animals. Prog. Lipid Res. 35 (1996), 371–385.
108. [108] Cao, H., Gerhold, K., Mayers, J.R., Wiest, M.M., Watkins, S.M., Hotamisligil, G.S., Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134 (2008), 933–944.
109. [109] Dobrzyn, A., Ntambi, J.M., The role of stearoyl-CoA desaturase in the control of metabolism. Prostaglandins Leukot. Essent. Fat. Acids 73 (2005), 35–41.
110. [110] Fu, S., Yang, L., Li, P., Hofmann, O., Dicker, L., Hide, W., Lin, X., Watkins, S.M., Ivanov, A.R., Hotamisligil, G.S., Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473 (2011), 528–531.
111. [111] Kitai, Y., Ariyama, H., Kono, N., Oikawa, D., Iwawaki, T., Arai, H., Membrane lipid saturation activates IRE1alpha without inducing clustering. Genes Cells 18 (2013), 798–809.
112. [112] Pinnamaneni, S.K., Southgate, R.J., Febbraio, M.A., Watt, M.J., Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro. Diabetologia 49 (2006), 3027–3037.
113. [113] Masuda, M., Miyazaki-Anzai, S., Keenan, A.L., Okamura, K., Kendrick, J., Chonchol, M., Offermanns, S., Ntambi, J.M., Kuro, O.M., Miyazaki, M., Saturated phosphatidic acids mediate saturated fatty acid-induced vascular calcification and lipotoxicity. J. Clin. Invest. 125 (2015), 4544–4558.
114. [114] Wang, C.W., Lipid droplets, lipophagy, and beyond. Biochim. Biophys. Acta 1861 (2016), 793–805.
115. [115] Csermely, P., Korcsmaros, T., Kiss, H.J., London, G., Nussinov, R., Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol. Ther. 138 (2013), 333–408.
116. [116] Koeberle, A., Werz, O., Multi-target approach for natural products in inflammation. Drug Discov. Today 19 (2014), 1871–1882.